{"organizations": [], "uuid": "a7438fee98d4cd3c5db79177008e3e1ef4948b38", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2017/01/09/104207626-GettyImages-452152866.1910x1000.jpg", "site_section": "https://www.cnbc.com/id/15839135/device/rss/rss.html", "section_title": "Earnings", "url": "https://www.cnbc.com/2018/04/18/abbotts-quarterly-profit-sales-beat-street-estimates.html", "country": "US", "domain_rank": 767, "title": "Abbott's quarterly profit, sales beat Street estimates", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T16:47:00.000+03:00", "replies_count": 0, "uuid": "a7438fee98d4cd3c5db79177008e3e1ef4948b38"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/04/18/abbotts-quarterly-profit-sales-beat-street-estimates.html", "ord_in_thread": 0, "title": "Abbott's quarterly profit, sales beat Street estimates", "locations": [], "entities": {"persons": [{"name": "abbott", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "abbott laboratories", "sentiment": "negative"}, {"name": "abbott", "sentiment": "none"}, {"name": "st. jude medical", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Abbott Laboratories reported better-than-expected quarterly profit and sales, helped by growth across its businesses and device launches.\nThe diversified health-care company reported net earnings of $418 million, or 23 cents per share, in the quarter ended March 31, compared to $419 million, or 24 cents per share, a year earlier.\nNet sales rose to $7.39 billion from $6.34 billion.\nExcluding items, Abbott reported a profit of 59 cents per share.\nAnalysts on average had expected profit of 58 cents per share on revenue of $7.29 billion, according to Thomson Reuters I/B/E/S.\nProfit from Abbott's medical device business — its largest division — continued to benefit from its $25 billion purchase of St. Jude Medical. Sales for the unit rose 14.6 percent to $2.74 billion in the quarter.", "external_links": [], "published": "2018-04-18T16:47:00.000+03:00", "crawled": "2018-04-18T16:25:37.016+03:00", "highlightTitle": ""}